photo These Borrelia Burgdorferi IgG and IgM Western Blot Assays are offered as second tier assays to provide serological evidence in support of a diagnosis of Lyme Disease.
     The assay is typically performed following a primary screening or other sensitive antibody assay such as an ELISA. The assay can provide indirect support of the clinician’s diagnosis, particularly when combined with other methods including the consideration of patient history and physical examination. Predictive value is highest when the likelihood of disease is high, based on clinical and epidemiological data.
     The assays, which can be performed in 95 minutes, are interpreted using the lot-specific guide provided by this company. The guide identifies significant bands, used to score each formation on the patient’s blot.
     Kits include enough strips and reagents to perform 32 determinations, the interpretation guide and a worksheet. It is manufactured using low-passage B-31 Borrelia burgdorferi antigen.
Zeus Scientific
www.zeusscientific.com
Keyword: assay, Lyme disease